Undisclosed PTPN1/2 inhibitor
/ Concentra Biosciences
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 25, 2025
iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025
(GlobeNewswire)
- "iTeos Therapeutics...announced the poster presentations of preclinical data on EOS-215, a potential best-in-class antibody targeting TREM2, and a novel small molecule inhibiting PTPN1/2 at the American Association for Cancer Research (AACR) Annual Meeting..."
Preclinical • Solid Tumor
1 to 1
Of
1
Go to page
1